Aficamten FDA approval date

The FDA approved Aficamten on 19 Dec 2025.

FDA approval date
19 Dec 2025

Drug identity checked against registry records

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-12-19DayAficamtenFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA219083", "applicant_as_listed_by_fda": "CYTOKINETICS", "brand_names": ["MYQORZO"], "active_ingredients": ["AFICAMTEN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20251219", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026